Status:
COMPLETED
Dexmedetomidine-Ketamine Infusion in Breast Surgeries
Lead Sponsor:
Tanta University
Conditions:
Total Intravenous Anesthesia
Eligibility:
FEMALE
50-70 years
Phase:
PHASE4
Brief Summary
* This is a prospective randomized double blind controlled study. * Female patients undergoing radical mastectomy will be included in this study where they will be randomly allocated into; - Control g...
Detailed Description
This prospective randomized controlled study will be carried out on 70 female patients who will be presented for radical mastectomy in the general surgery department in Tanta university hospitals over...
Eligibility Criteria
Inclusion
- Female patients aged 50-70 years, ASA class I-III, and presented for elective radical mastectomy.
Exclusion
- Patients refused to participate.
- Patients with known or suspected or known allergy to the used medication.
- Patients with preoperative chronic pain,
- Patients received preoperative opioids or gabapentoids.
- Patients with major cardiac, renal, respiratory, or hepatic disease.
- Uncooperative patients.
- Obese patients with BMI \>36
Key Trial Info
Start Date :
September 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 20 2024
Estimated Enrollment :
103 Patients enrolled
Trial Details
Trial ID
NCT04048226
Start Date
September 1 2019
End Date
March 20 2024
Last Update
April 30 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tanta University hospitals
Tanta, Egypt, 31511